Kyntra Bio (KYNB) Revenue (2014 - 2026)
Kyntra Bio's Revenue came in at $1.47 million for Q2 2026, up 9.3% from $1.35 million a year earlier but down 60.6% from the prior quarter.
Kyntra Bio (KYNB) Revenue (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Kyntra Bio reported Revenue of $7.57 million, up 3.0% year-over-year; for FY2025, it was $6.44 million, down 78.3% from FY2024.
- Revenue has declined in each of the last four years, with a five-year compound annual growth rate of -48.4% (FY2020 to FY2025).
- Going back by year, Revenue was $29.62 million in FY2024 (-36.7%), $46.8 million in FY2023 (-66.7%), $140.73 million in FY2022 (-40.2%) and $235.31 million in FY2021 (+33.5%).
- The five-year range for quarterly Revenue is -$73.81 million (Q4 2023) to $155.97 million (Q3 2021).
- Year-over-year, Revenue increased in four of the last seven quarters, with growth averaging 86.8%.
- The fastest year-over-year change in Revenue over five years came in Q3 2025 (growth of 774.8%), and the weakest in Q3 2024 (a decline of 99.7%).
- Business Quant data shows KYNB's Revenue at $3.74 million (Q1 2026), $1.28 million (Q4 2025) and $1.08 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,135.43 Bn | 1,104.02 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 616.54 Bn | 535.06 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 501.55 Bn | 474.66 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 367.19 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 297.91 Bn | 261.90 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.40 Bn | 235.09 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 236.18 Bn | 191.58 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 190.55 Bn | 164.75 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 169.40 Bn | 116.05 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Kyntra Bio | 21.21 Mn | -386.73 Mn | 1.47 Mn | 1.47 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.47 Mn |
| Mar 31, 2026 | 3.74 Mn |
| Dec 31, 2025 | 1.28 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | 2.74 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 123,000.00 |
| Jun 30, 2024 | 998,000.00 |
| Mar 31, 2024 | 25.36 Mn |
| Dec 31, 2023 | -73.81 Mn |
| Sep 30, 2023 | 40.13 Mn |
| Jun 30, 2023 | 44.32 Mn |
| Mar 31, 2023 | 36.16 Mn |
| Dec 31, 2022 | 34.37 Mn |
| Sep 30, 2022 | 15.74 Mn |
| Jun 30, 2022 | 29.81 Mn |
| Mar 31, 2022 | 60.83 Mn |
| Dec 31, 2021 | 16.54 Mn |
| Sep 30, 2021 | 155.97 Mn |
Kyntra Bio Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=KYNB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "KYNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=KYNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();